| Sep 15, 2026 | Jonathan Sheena | — | SELL | 9.150K | $351.49 | $3.2M |
| Sep 14, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 102.000K | $341.15 | $34.8M |
| Sep 11, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 50.000K | $327.97 | $16.4M |
| Sep 1, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 18.160K | $325.88 | $5.9M |
| Sep 1, 2026 | Leonard Steven Chapman | CEO AND PRESIDENT | SELL | 1.698K | $320.99 | $545K |
| Aug 10, 2026 | Jonathan Sheena | — | SELL | 6.000K | $325.32 | $2.0M |
| Aug 7, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 2.000K | $320.90 | $642K |
| Aug 7, 2026 | Jonathan Sheena | — | SELL | 9.150K | $315.66 | $2.9M |
| Aug 6, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | GRANT | 13.483K | $321.53 | $2.1M |
| Aug 3, 2026 | Burkes Michael Brophy | CHIEF FINANCIAL OFFICER | SELL | 795.000 | $271.74 | $216K |
| Aug 3, 2026 | Leonard Steven Chapman | CEO AND PRESIDENT | SELL | 3.076K | $266.39 | $819K |
| Aug 3, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 295.000 | $267.99 | $79K |
| Aug 3, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 3.410K | $265.58 | $906K |
| Aug 3, 2026 | DANIEL RABINOWITZ | SEC. AND CHIEF LEGAL OFFICER | SELL | 334.000 | $267.99 | $90K |
| Aug 3, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 731.000 | $267.99 | $196K |
| Aug 3, 2026 | Jonathan Sheena | — | SELL | 109.000 | $267.99 | $29K |
| Jul 27, 2026 | Jonathan Sheena | — | SELL | 479.000 | $257.93 | $124K |
| Jul 27, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 1.718K | $260.49 | $448K |
| Jul 27, 2026 | DANIEL RABINOWITZ | SEC. AND CHIEF LEGAL OFFICER | SELL | 1.887K | $257.08 | $485K |
| Jul 27, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 2.214K | $257.00 | $569K |
| Jul 27, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 1.713K | $257.00 | $440K |
| Jul 27, 2026 | Leonard Steven Chapman | CEO AND PRESIDENT | SELL | 5.770K | $256.51 | $1.5M |
| Jul 27, 2026 | Burkes Michael Brophy | CHIEF FINANCIAL OFFICER | SELL | 5.064K | $253.28 | $1.3M |
| Jul 15, 2026 | Jonathan Sheena | — | SELL | 1.500K | $273.88 | $411K |
| Jul 15, 2026 | Rowan Chapman | — | SELL | 135.000 | $274.82 | $37K |
| Jul 13, 2026 | Jonathan Sheena | — | SELL | 3.150K | $265.68 | $837K |
| Jul 6, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 1.000K | $280.00 | $280K |
| Jul 1, 2026 | DANIEL RABINOWITZ | SEC. AND CHIEF LEGAL OFFICER | SELL | 16.800K | $272.29 | $4.6M |
| Jul 1, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 3.000K | $272.90 | $819K |
| Jun 24, 2026 | DANIEL RABINOWITZ | SEC. AND CHIEF LEGAL OFFICER | SELL | 33.600K | $251.65 | $8.5M |
| Jun 24, 2026 | HERM ROSENMAN | — | SELL | 16.530K | $250.00 | $4.1M |
| Jun 17, 2026 | Jonathan Sheena | — | SELL | 1.500K | $219.87 | $330K |
| Jun 16, 2026 | Rowan Chapman | — | SELL | 2.964K | $216.78 | $643K |
| Jun 15, 2026 | Jonathan Sheena | — | SELL | 3.150K | $211.14 | $665K |
| Jun 12, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 100.000K | $214.47 | $21.4M |
| Jun 5, 2026 | Boxer Gail Marcus | — | SELL-OPTIONS | — | $120.02 | $2.1M |
| Jun 4, 2026 | Leonard Steven Chapman | CEO AND PRESIDENT | SELL | 41.124K | $221.03 | $9.1M |
| Jun 1, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 3.000K | $218.43 | $655K |
| Jun 1, 2026 | Roelof Botha | DIRECTOR | SELL | 78.000K | $220.31 | $17.2M |
| May 26, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.652K | $202.84 | $335K |
| May 26, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 1.438K | $202.84 | $292K |
| May 8, 2026 | Jonathan Sheena | — | SELL | 4.650K | $206.33 | $959K |
| May 4, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 5.319K | $213.05 | $1.6M |
| May 1, 2026 | Burkes Michael Brophy | CHIEF FINANCIAL OFFICER | SELL | 795.000 | $208.79 | $166K |
| May 1, 2026 | Jonathan Sheena | — | SELL | 107.000 | $206.16 | $22K |
| May 1, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 3.405K | $203.69 | $694K |
| May 1, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 291.000 | $206.16 | $60K |
| May 1, 2026 | Leonard Steven Chapman | CEO AND PRESIDENT | SELL | 902.000 | $206.16 | $186K |
| May 1, 2026 | DANIEL RABINOWITZ | SEC. AND CHIEF LEGAL OFFICER | SELL | 330.000 | $206.16 | $68K |
| Apr 27, 2026 | Burkes Michael Brophy | CHIEF FINANCIAL OFFICER | SELL | 5.063K | $197.84 | $1.0M |
